RVTY
REVVITY, INC.
Next earnings Jul 27, 2026 (before open) · consensus $1.25 EPS, $725M rev
Last earnings +6.7% on 2026-05-05
$113.76
▲ +2.29%$113.76▲ +16.63%
over 1Y
L $82.26H $117.66
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.3%
1W+0.2%
1M+13.3%
3M+28.0%
YTD+16.1%
1Y+16.6%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 24 analysts
Buy
High-margin life-sciences tools franchise buying back stock, but growth is sluggish and GAAP earnings look pricey.
Revenue $2.86B · FY2025
The read
Middling fundamentals and a rich price (~86% above fair value) leave little margin of safety — a wait-and-see.
Revvity (the former PerkinElmer life-sciences and diagnostics business) is a high-quality but currently slow-growing tools company. FY2025 revenue grew just 3.7% to $2.86B, with a strong 69.7% gross margin but a modest 12.5% operating margin and only an 8.4% net margin. The headline 48.3 P/E on $2.07 of diluted EPS overstates how expensive it is: net income of $241M is heavily depressed by $405M of depreciation and amortization, much of it acquisition-related intangible amortization, so cash earnings and adjusted EPS are materially higher than GAAP. Operating cash flow of $583M against $241M of net income confirms the gap.
Capital allocation is shareholder-friendly: the company repurchased $821M of stock (up 122%), cutting shares outstanding 7.0%, and paid a small $32.8M dividend. The balance sheet is healthy — $7.25B of equity against $4.92B of liabilities (0.68x) and $920M of cash — though long-term debt of $2.63B fell 16.5% even as a large current-debt maturity moved up (current liabilities doubled), a refinancing item to watch.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:49 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $2.66B | $3.83B | $2.75B | $2.76B | $2.86B |
| Gross profit | $2.11B | $2.43B | $1.99B | — | — |
| Operating income | $867M | $1.26B | $301M | $347M | $357M |
| Net income | $728M | $943M | $693M | $270M | $241M |
| Diluted EPS | $6.49 | $8.08 | $5.55 | $2.20 | $2.07 |
| Net margin | 27.3% | 24.6% | 25.2% | 9.8% | 8.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$15.0B
EV / EBITDA19.7
EV / Sales5.2
EV / FCF29.4
P / FCF24.9
PEG (trailing)—
Earnings yield1.9%
FCF yield4.0%
Quality & risk
ROIC (est.)2.7%
Free cash flow$509M
Total debt$3.22B
Net cash-$2.30B
Altman Z-Score2.67 grey
Piotroski F-Score6/9
Capital returns
Buyback yield6.5%
Dividend yield (est.)0.3%
Shareholder yield6.7%
Shares Δ YoY-7.0%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRoutine disclosure cadence — no material red flags in recent filings.
Recent filings
all on EDGAR ↗11-KPeriod ending 2025-12-312026-06-23open ↗4Period ending 2026-06-152026-06-17open ↗SDFiling2026-06-01open ↗SCHEDULE 13G/AFiling2026-05-15open ↗10-QPeriod ending 2026-04-052026-05-12open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗4Period ending 2026-05-072026-05-11open ↗
Frequently asked
- Is REVVITY, INC. (RVTY) a buy?
- RVTY currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. High-margin life-sciences tools franchise buying back stock, but growth is sluggish and GAAP earnings look pricey.
- What is RVTY's fair value?
- A Modified-Graham model based on RVTY's SEC fundamentals estimates a fair value of about $15.84. It is an estimate from reported earnings, not a price target.
- Is RVTY overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, RVTY currently appears overvalued relative to its SEC-grounded earnings power.
- What is REVVITY, INC.'s quality score?
- RVTY scores 61.20435879096815/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0000031791, latest 10-Q filed 2026-05-12) · EODHD · Proprietary analysis · as of 6/21/2026, 8:49:28 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.